CDK4 and acute lymphoblastic leukemia: The most effective degrader 170 (YX-2-107, Fig. 45) induced the rapid and selective degradation of CDK6 over CDK4 in Ph-positive ALL cells, and significantly inhibited S-phase cells and inhibited the expression of phosphor-RB and FoxM1 regulated by CDK6.